School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Electra Therapeutics, Inc. ETRA

Healthcare · Biotechnology

$9.41last close 2026-10-12 · market cap $586.56M · delayed data

What it does

Electra Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company develops therapies that targets signal regulatory proteins for the treatment of novel targets for treatment of immune-mediated diseases and cancer.

Open ETRA in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies